<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02625428</url>
  </required_header>
  <id_info>
    <org_study_id>14-009240</org_study_id>
    <nct_id>NCT02625428</nct_id>
  </id_info>
  <brief_title>IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?</brief_title>
  <official_title>Does Contrast-Enhanced Ultrasound Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to investigate whether contrast-enhanced ultrasound (CEUS) may help
      evaluate segmental differences in renal perfusion better than Doppler Ultrasound and thus
      help direct the biopsy to the most abnormal part of the renal cortex. This should maximize
      detection and increase the odds of demonstrating the true grade/severity of the
      histopathological abnormality.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients in which a renal transplant biopsy targeted using CEUS finds a higher degree of rejection compared to a non-targeted biopsy.</measure>
    <time_frame>40 patients, 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with a higher degree of renal transplant rejection using multiple biopsies compared to a single biopsy.</measure>
    <time_frame>40 patients, 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Transplantation, Kidney</condition>
  <arm_group>
    <arm_group_label>FC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>biopsy to evaluate a recent rise in serum creatinine so called for cause biopsies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>done at 4 months and 1 year after transplant mostly looking for subclinical rejection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Optison</intervention_name>
    <arm_group_label>FC</arm_group_label>
    <arm_group_label>S</arm_group_label>
    <other_name>ultrasound contrast agent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion

          -  Ability to provide informed consent

          -  Male and female &gt;18 years

          -  Patients undergoing renal transplant ultrasound-guided percutaneous biopsy within 24
             months post transplant including patients undergoing biopsy to evaluate a recent rise
             in serum creatinine so called for cause biopsies and patients undergoing routine
             protocol (surveillance) biopsies without other evident of renal dysfunction

        Exclusion:

          -  Pregnant women or women who are nursing an infant are not able to participate in this
             study

          -  Known patent forearm ovale (PFO)

          -  Significant heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J Kriegshauser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra R. Kavuma, B.S.</last_name>
      <phone>480-342-0349</phone>
      <email>kavuma.sandra@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>J. Scott Kriegshauser, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2015</study_first_submitted>
  <study_first_submitted_qc>December 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2015</study_first_posted>
  <last_update_submitted>October 18, 2017</last_update_submitted>
  <last_update_submitted_qc>October 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>J. Scott Kriegshauser, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

